Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variations in immune mediators and prostate cancer risk: A field synopsis with Bayesian calculations.

Cytokine - 1 Jul 2024

Santos Freire Matheus, Victor de Oliveira Monteiro André, Moura Martins Tayane, Socorro Silva Lima Duarte Márcia, Carlos Lima Antonio, Luiz Araújo Bentes Leal Alessandro, Rodolfo Pereira da Silva Felipe, Fernando Marques Barcellos José

Abstract excerpt

OBJECTIVE: Our study aimed to revaluate the significant data from meta-analyses on genetic variations in immune mediators and the risk of prostate cancer (PCa) by Bayesian approaches. METHODS: We performed a search on the literature before September 5th, 2023, for meta-analytic studies on polymorphisms in immune mediator genes and the risk of PCa. Two Bayesian approaches were used to assess the level of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bayes Theorem
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Interleukin-1beta

Share to Meta-Analysis as Topic

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 38696882
DOI: 10.1016/j.cyto.2024.156630

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variations in immune mediators and prostate cancer risk: A field synopsis with Bayesian calculations.PMID 38696882Read ↗

Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancerSemantic proximity Read ↗

Causal relationship between immune cells and prostate cancer: a Mendelian randomization studySemantic proximity Read ↗

Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.Semantic proximity Read ↗

A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.Semantic proximity Read ↗

Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization studySemantic proximity Read ↗

Interactions of cytokine gene polymorphisms in prostate cancer risk.Semantic proximity Read ↗

[Inflammatory factors and prostate cancer: Two-sample Mendelian randomization analysis].Semantic proximity Read ↗

Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development.Semantic proximity Read ↗

Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian RandomizationSemantic proximity Read ↗

Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study.Semantic proximity Read ↗

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancerSemantic proximity Read ↗

Developing an immune‐related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.